Xpect Stopain Clinical Gel
Product Images NDC 42961-256

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Xpect Stopain Clinical (NDC 42961-256). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cintas Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Packet1 (Packet1)

Packet1 (Packet1)
Label of Xpect Stopain Clinical 100 mg/g Menthol topical gel. The label highlights it as a maximum performance pain relief gel providing immediate, penetrating relief from arthritis, muscle aches, and joint & back pain. It contains 10% menthol with MSM and glucosamine. Labeler is Cintas Corporation with a net weight of 3 grams.*
FDA Label Image

Packet2 (Packet2)

Packet2 (Packet2)
Drug Facts panel for Xpect Stopain Clinical Gel with active ingredient Menthol 10.0%, a topical analgesic. The panel includes uses for minor aches, pains, and related conditions, warnings about external use and flammability, directions for adults and children over 2 years, and other information such as storage instructions and inactive ingredients. Manufacturer is Cintas Corporation, Mason, OH.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.